For instance, a controlled trial in patients with severe atopic dermatitis showed that monthly IVIG infusions at 2 g/kg reduced disease severity and lowered Th2 cytokine levels, such as interleukin-5 (33)​. Here, IL5 is linked to atopic eczema.